抑制替代补充系统和prolyl氧酶可以改善炎症性贫血
Vishal J Patel1, Amit A Joharapurkar2, Samadhan G Kshirsagar1
1Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Sarkhej Bavla NH 8A, Moraiya, Ahmedabad, 382210, India.
Inflammopharmacology
|November 23, 2024
概括
这项研究表明,结合伊普塔科潘和脱沙斯塔特可以有效地治疗大鼠的炎症性贫血,通过减少红细胞的破坏和改善铁含量. 组合疗法为管理这种疾病提供了一个有希望的新方法.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性炎症导致红细胞 (RBC) 破坏和贫血,通过涉及补充系统和铁平衡受损的机制.
- 炎症性贫血的特点是红色素减少和功能性铁缺乏,导致红细胞损失.
研究的目的:
- 调查伊普塔科潘 (B因子抑制剂) 和德希苏斯塔特 (普罗利氧化酶抑制剂) 对大鼠糖多糖化物 (PGPS) 诱导的炎症性贫血的治疗作用.
- 评估iptacopan和desidustat在缓解炎症,血液溶解和贫血方面的联合疗效.
主要方法:
- 鼠被用PGPS治疗以诱发炎症和贫血,然后给它们服用脱沙斯塔特和/或伊普塔科潘两周.
- 评估的标志物包括血液溶解指标 (LDH,总胆红素,红细胞寿命),血液学参数 (血红蛋白,红细胞计数),铁稳定标志物 (血清铁,肝素) 和炎症标志物 (WBC,脚体积).
主要成果:
- 结合伊普塔科潘和脱苏的联合治疗显著预防了血液溶解,并减少了炎症标志物.
- 组合治疗导致血红蛋白和红细胞计数的早期正常化,血清铁水平的改善,脏重量和肝素的减少.
- 仅德西杜沙特对铁代谢和肝素水平有显著影响.
结论:
- 伊普塔科潘和脱希斯塔特的组合显示出作为治疗治疗炎症性贫血的治疗策略的巨大潜力.
- 针对补充介导血液溶解和铁失调提供了一种双重方法来治疗这种复杂的疾病.
相关概念视频
01:23Antimicrobial Proteins
907
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
907
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:28Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
01:38Inflammation
52.7K
Overview
52.7K